Sue Currie, Ph.D.

Chief Operating Officer

Dr. Sue Currie serves as Chief Operating Officer of Virion Therapeutics, LLC. She has 20+ years of strategic, operational, and scientific leadership experience in clinical research and development programs, from the discovery phase to post-launch, with a focus on cancers and infectious diseases. Prior to joining Virion, she was Vice President, Head of Medical Affairs, at Nektar Therapeutics where she had responsibilities that included global executive and corporate leadership roles within the Company and was a core member of the Research and Development senior leadership team. Dr. Currie has biotech organizational leadership experience, but also has been instrumental in the study design and strategies for clinical programs, as well as the scientific analyses and dissemination of these data, in various forums. In this element, she has experience developing and building out new clinical functions and teams, including medical affairs and other related activities. Prior to Nektar, Dr. Currie held Senior positions at Genentech/Roche and Health Interactions, the latter of which she oversaw all US Operations and a team of almost 200 persons. 


She has authored numerous pivotal scientific publications in both immuno-oncology, as well as infectious diseases, including HIV, HCV, and Coinfection treatment guidelines. Additionally, she has been a leader in external and internal health educational global and national programs and clinical resources for healthcare providers and other stakeholders in hepatitis and liver diseases, as well as oncology.


Dr. Currie received her BA&S (Hon) from University of Saskatchewan, Saskatoon, Canada, her MA, from University of Phoenix, Vancouver, Canada, and her Ph.D from the University of San Francisco, San Francisco, USA. Sue brings with her a patient-centric focus to her operational and clinical leadership, from her Veterans Health Administration, academic, correctional health, and community care setting experiences.